Latest Diabetes News
The advice is useful as clinicians wait for formal guidelines.
Small whey preload augments plasma intact GLP-1 levels, slows gastric emptying.
Eight weeks of high-dose treatment has no impact on -cell function, insulin sensitivity, glycemic control.
Carbamazepine co-treatment linked to subtherapeutic anticoagulative effect of warfarin.
Follow-up of patients from ACCORD trial shows neutral effect on primary composite outcome.
Overall albuminuria drop may be too small for cardiovascular, renal risk protection.
Serious hypoglycemia linked to progression of CAC only in standard therapy group of VA Diabetes Trial.
But the research is preliminary and only included a small number of healthy young men.
180 mg/dL or greater tied to worse outcomes for most patients; not for those with insulin-treated diabetes.
Association not seen for patients treated with background metformin therapy.
No correlation between hospitalization with DDP-4is versus sulfonylureas, or saxagliptin versus sitagliptin.
Independent correlation persisted after adjustment for cardiovascular risk factors.
Black race, severe hypoglycemia, insulin use linked to failure to reach HbA1c target in ACCORD trial.
Proportion of patients currently on any insulin stable from 1988-1994 to 1999-2012.
Severe hypoglycemia may result in changes in mental state, seizures, arrhythmias, coma, and death.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)